Project Grant R01NS135401
Award Date
7/1/24
Completion Date
6/30/29
Dollars Obligated
$498K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) project grant award, with CFDA number 93.279 for Drug Use and Addiction Research Programs, provides $154,568 in funding to The Washington University in St. Louis to conduct research on the role of endogenous opioids in the dorsal raphe nucleus (DRN) and their contribution to motivational and affective behavioral dysfunction during chronic pain. The 3.5-year project, running from June 2025 to December 2028, aims...
This Project Grant award, valued at $597,999.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The funding supports research at the University of Pittsburgh focused on understanding the neuronal populations and central sensitization mechanisms underlying mechanical allodynia, a type of persistent pain, in the dorsal horn. Key objectives include...
This $1,587,553 Project Grant was awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support a multidisciplinary team of researchers at Washington University to develop and characterize novel central nervous system (CNS)-penetrant 5-HT3 receptor antagonists as potential drug candidates for treating neuropathic pain.
Through the project, the researchers will utilize structure-based...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,511,970 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Saint Louis University to develop selective GPR34 antagonists for the treatment of neuropathic pain. The project aims to establish the biological rationale and infrastructure for advancing novel non-opioid based GPR34 antagonists as potential drug candidates for neuropathic pain, which affects 15-20 million people in the U.S. The...
This federal Project Grant award of $675,107 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to develop novel non-opioid, non-addictive analgesics for treating neuropathic pain. The award funds a collaborative research effort across five laboratories to design, synthesize, and evaluate a series of "dualsteric" cannabinoid receptor ligands...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $441,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Duquesne University of the Holy Spirit. The purpose of this 3-year grant, beginning September 2023, is to utilize laboratory data and computational 3-D modeling to analyze the role of the central amygdala in neuropathic pain. Specifically, the project aims to build a proof-of-concept 3-D...
This $246,750 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research to investigate the role of the mesocortical glutamatergic pathway in the development and maintenance of chronic neuropathic pain.
The research project aims to examine how changes in glutamatergic inputs from the ventral tegmental area (VTA) to the prefrontal cortex...
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the role of the nuclear receptor NR4A1 in pain resolution and its potential as a therapeutic target for chronic pain and opioid misuse. The $2,103,564 award to the University of Cincinnati will fund research over 3 years to test the hypothesis that NR4A1 in macrophages controls inflammation resolution...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is funding research to investigate the neural circuits involved in pain perception and the relationship between pain and depression.
The $643,262 award to the University of California, San Francisco will support studies examining how the lateral habenula brain region...
This $1,525,066 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research focused on understanding the complex mechanisms underlying chronic pain. The study aims to elucidate how somatosensory, cognitive, and affective information is integrated in corticothalamic brain networks to produce the experience of chronic pain. Through direct...